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ABSTRACT
Autophagy is activated early after human cytomegalovirus (HCMV) infection but, later on, the virus blocks
autophagy. Here we characterized 2 HCMV proteins, TRS1 and IRS1, which inhibit autophagy during
infection. Expression of either TRS1 or IRS1 was able to block autophagy in different cell lines,
independently of the EIF2S1 kinase, EIF2AK2/PKR. Instead, TRS1 and IRS1 interacted with the autophagy
protein BECN1/Beclin 1. We mapped the BECN1-binding domain (BBD) of IRS1 and TRS1 and found it to be
essential for autophagy inhibition. Mutant viruses that express only IRS1 or TRS1 partially controlled
autophagy, whereas a double mutant virus expressing neither protein stimulated autophagy. A mutant
virus that did not express IRS1 and expressed a truncated form of TRS1 in which the BBD was deleted,
failed to control autophagy. However, this mutant virus had similar replication kinetics as wild-type virus,
suggesting that autophagy inhibition is not critical for viral replication. In fact, using pharmacological
modulators of autophagy and inhibition of autophagy by shRNA knockdown, we discovered that
stimulating autophagy enhanced viral replication. Conversely, inhibiting autophagy decreased HCMV






Autophagy is an evolutionarily conserved degradation process,
which has been described as a self-defense mechanism against
intracellular microorganisms.1,2 Indeed, autophagy can partic-
ipate in the control of viral infection by direct degradation of
viral components, by regulating the intensity of the inflamma-
tory response or by facilitating the processing of viral antigens
for presentation by major histocompatibility complex
(MHC).3 Autophagy induction can therefore be detrimental
for viral infections, but also beneficial, when it is hijacked and
regulated by viruses. Indeed, in addition to its recognized role
as a scaffold platform for replication of positive-strand RNA
viruses, autophagy contributes to viral infectivity through
multiple mechanisms. This cellular process can provide
energy, lipid membranes, or a vehicle for the virus to get out
the cell and can also improve the survival of the infected cell
and thereby increase viral production.4,5 Viruses can also spe-
cifically redirect cellular signaling mediators to autophagoso-
mal degradation to dampen the inflammatory response.6 On
the other hand, autophagy enhances the delivery of viral anti-
gens to MHC class I and II complexes and improves antigen
presentation. For example, presentation of 3 antigens of
human cytomegalovirus (HCMV), classically processed in a
proteasome-dependent manner, has been described to also
occur via a vacuolar pathway involving autophagosomes, lyso-
somal proteases, and recycling HLA-molecules.7 Interestingly,
we and others have previously demonstrated that HCMV
modulates autophagy during its life cycle, stimulating auto-
phagic flux shortly after its entry.8,9 Then, after 18 to 24 h of
infection, autophagosome formation is blocked by expression
of viral proteins.8
HCMV is a ubiquitous opportunistic pathogen virus, which,
like other viruses in the Herpesviridae family, has the ability to
persist in the host in an inactive state known as latency after
the primary infection subsides. HCMV infections in immuno-
compromised patients cause substantial morbidity and mortal-
ity, especially among transplant recipients, while infection in
immunocompetent individuals is generally mild or asymptom-
atic. Studies of HCMV multiplication in vitro showed that viral
cycle occurs in a series of stages. After entry of the nucleocapsid
into the cell, the viral genome is delivered to the nucleus to be
transcribed and replicated. Transcription is a complex process
with 3 classes of proteins that need to be made for production
of mature virions. Synthesis of immediate early proteins, which
are nonstructural proteins involved in transcriptional regula-
tion, is followed by expression of early genes, encoding proteins
CONTACT Audrey Esclatine audrey.esclatine@u-psud.fr Institute for Integrative Biology of the Cell (I2BC), 5 rue Jean Baptiste Clement, Faculte de Pharmacie,
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mainly involved in viral DNA replication. Synthesis of late pro-
teins, structural components of the virus, is initiated after repli-
cation of the viral genome. Viral nucleocapsids assemble within
the nucleus and bud across both the inner and outer nuclear
membranes to transit to the cytoplasm. Naked cytoplasmic
nucleocapsids acquire their tegument and then their final enve-
lope from the trans-Golgi network or from the endocytic path-
way.10 Mature virions are transported inside vacuoles to the
cell surface to be secreted.
HCMV has a linear 235-kbp double-stranded DNA genome
with an estimated coding capacity between 160 and 200 open
reading frames (ORFs) or even possibly as many as »750
ORFs, as predicted by recent ribosomal profiling studies.11 The
genome consists of 2 regions of unique sequences, flanked by 2
sets of inverted repeats (TRL-IRL) and (IRS-TRS). Partially
located in one set of inverted repeats, IRS1 and TRS1 ORFs
encode 2 immediate early proteins of 847 and 795 amino acids,
respectively, with identical N-terminal domains and divergent
C-terminal regions.12 IRS1 and TRS1 have been reported to
inhibit the phosphorylation of the translation initiation factor
EIF2S1, preventing the shutoff of cellular protein synthesis that
occurs upon infection.13,14 They are able to rescue the function
of the vaccinia virus E3L protein, in VVDE3L infected cells, to
prevent activation of the kinase EIF2AK2/PKR (eukaryotic
translation initiation factor 2-a kinase 2).13 When EIF2AK2
binds to double-stranded RNA (dsRNA), it dimerizes and auto-
phosphorylates and then, it phosphorylates its substrate
EIF2S1. Phosphorylated EIF2S1 inhibits guanine nucleotide
exchange factor EIF2B, resulting in a shutdown of protein syn-
thesis that in turn hinders viral production. Herpesviruses pro-
duce dsRNA during infection, likely as a result of hybridization
of convergent overlapping mRNAs. IRS1 and TRS1 bind to
both dsRNA and EIF2AK2 to block EIF2AK2 and that these
interactions require their carboxy termini.15-17 Because TRS1
antagonized EIF2AK2 and the product of activated EIF2AK2,
phosphorylated EIF2S1, can activate autophagy,18 we tested the
impact of TRS1 and found that it inhibited autophagy.8
Here we explored the functions of TRS1 and IRS1 as regula-
tors of autophagy by HCMV using recombinant viruses. We
show that each protein is able to block autophagy in the context
of HCMV replication and that an N-terminal domain that is
identical in the 2 proteins is essential for this function. Coex-
pression of both TRS1 and IRS1 is necessary to block autopha-
gic flux. However, blocking autophagy appears not to be
essential for viral replication. In fact, analyses employing phar-
macological modulators of autophagy and depletion of
ATG16L1 suggest that autophagy plays a proviral role in the
HCMV cell cycle.
Results
IRS1 and TRS1 both inhibit starvation-induced autophagy
We used several assays to investigate the impact of the 2
HCMV proteins TRS1 and IRS1 on autophagy. First, we tran-
siently transfected HeLa cells that stably express GFP-LC3B
with an IRS1 or TRS1 expression vector or with an empty vec-
tor. After inducing autophagy by starvation for 4 h prior to fix-
ation, we quantified GFP-LC3 dots in cells expressing viral
proteins. Figure 1A and B shows that the number of LC3 dots
per cell was lower in HeLa cells expressing IRS1 and TRS1 than
in control cells. To confirm these findings, we optimized an
automated quantification of GFP-LC3 dots using a Cellomics
ArrayScan microscope (Fig. 1C). We measured several parame-
ters including the number of GFP-LC3 dots per cell, the total
intensity per cell, and the total area in the cells that was covered
by GFP-LC3 dots, and the average area of individual GFP-LC3
dots. Cells transfected with IRS1 or TRS1 displayed reduction
of these 3 former parameters, confirming a global decrease in
the number of autophagosomes. Only the size of the autopha-
gosomes (GFP-LC3 spot average area) was not modified by
IRS1 or TRS1 expression, indicating that the decrease in the
average number of dots is not simply due to fusion of several
autophagosomes.
We also used immunofluorescence studies to measure the
abundance of SQSTM1/p62 (sequestosome 1), an autophagic
substrate located within autophagosomes (Fig. 1D and E). In
our system, we observed that starvation increased the number
of SQSTM1 dots compared to basal conditions, whereas 3-
methyladenine, a classic autophagy inhibitor, diminished them
(Fig. 1D). A reduction of SQSTM1 dots in HeLa cells express-
ing IRS1 or TRS1 confirmed that these proteins inhibited
autophagy. Finally, we monitored SQSTM1 and LC3-II by
immunoblot in normal conditions (complete medium) and
after starvation (Fig. 1F). We observed an accumulation of
SQSTM1 and a decrease of LC3-II, by immunoblot after IRS1
or TRS1 expression, compared to starved cells and even to cells
cultured in normal conditions, which correspond to an inhibi-
tion of autophagy. We used the viral protein ICP34.5, an HSV-
1 protein that has been previously reported to block autophagy,
as a positive control in this experiment.19 Taken together, these
results demonstrate that IRS1 and TRS1 are each able to block
the formation of autophagosomes.
IRS1 and TRS1 inhibit autophagy independently of
EIF2AK2
In order to investigate the mechanism of the autophagy inhibi-
tion by these 2 proteins, we investigated the role of the double-
stranded RNA (dsRNA)-dependent kinase EIF2AK2. Indeed,
we have recently identified a viral protein encoded by HSV-1
that blocks autophagy by interaction with EIF2AK2.20 More-
over, TRS1 and IRS1 bind to dsRNA and EIF2AK2 to prevent
the shutoff of protein synthesis.14-16 In order to explore
whether the interaction between EIF2AK2 and the viral pro-
teins is involved in the inhibition of autophagy, we performed
assays in murine embryonic fibroblasts (MEFs) that have or
lack EIF2AK2. We transiently cotransfected Eif2ak2C/C and
eif2ak2¡/¡ MEFs with GFP-LC3 and either IRS1 or TRS1
expression vectors then induced autophagy by starvation. Con-
sistent with our previous analyses of TRS1, we observed that
both IRS1 and TRS1 decreased the number of autophagosomes,
independently of the expression of EIF2AK2 (Fig. 2A and B).8
We also monitored SQSTM1 accumulation by immunoblot
assay of lysates of Eif2ak2C/C and eif2ak2¡/¡ MEFs in normal
conditions and after starvation (Fig. 2C). We observed that
expression of TRS1 or IRS1 induced accumulation of SQSTM1
in both cell lines. These results suggest that IRS1, like TRS1,
blocks autophagy independently of EIF2AK2.
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IRS1 contains a EIF2AK2 binding domain located in the C-
terminal domain (an essential component of which lies between
amino acids 669 and 692).16 We transiently transfected HeLa
cells stably expressing GFP-LC3, with full length or C-terminal
truncations of IRS1 (Fig. 2D). We observed that the truncated
forms of IRS1 blocked LC3 dots accumulation (Fig. 2E and F).
We also observed by immunoblot an accumulation of SQSTM1
and a decrease of LC3-II in HeLa cells transfected with the dif-
ferent IRS1 constructs (Fig. 2G). Taken together, our results
showed that all C-terminally truncated IRS1 proteins inhibited
Figure 1. Inhibition of starvation-induced autophagy by ectopic expression of TRS1 and IRS1. (A) Representative images of GFP-LC3 HeLa cells transfected with an empty
vector (vector), IRS1, or TRS1 plasmids and then fixed after starvation. (B) The number of GFP-LC3-dots in TRS1 or IRS1-expressing cells in the transfected HeLa cells was
quantified. The results are the mean of 6 independent experiments; 50 to 100 cells were analyzed per assay. (C) (Microscopy panels). (Left) Cellomics ArrayScan images of
GFP-LC3 HeLa cells transfected with empty vector, IRS1 or TRS1. (Right) Image analysis software detected DAPI-labeled nuclei (blue), cell outline (red line), GFP-LC3 dots
(green dots) and nontransfected cell nuclei (yellow line). The number of GFP-LC3 dots per cell, total intensity, total area and average area were quantified using Cellomics
spot detector software. (D) (Top panel) SQSTM1 staining in HeLa cells under starvation or after 3-methyladenine (3MA) treatment. (Lower panel) SQSTM1 staining in HeLa
cells expressing IRS1 or TRS1 and after starvation. (E) Autophagy was quantified by counting the number of SQSTM1 dots per transfected cell. The results are the mean of
3 independent experiments; 20 cells were analyzed per assay. (F) Immunoblot analysis of SQSTM1 and LC3 proteins in HeLa cells transfected with IRS1, TRS1 or ICP34.5
plasmids. CM, complete medium. ACTB was used as a loading control. , P<0.01; , P<0.001 (One-way ANOVA).
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starvation-induced autophagy (Fig. 2E to G). Notably, the
region of IRS1 between codon 655 and 692, which is essential
for EIF2AK2-binding, is not required for autophagy inhibition.
We obtained similar results with TRS1.8
IRS1 and TRS1 inhibit autophagy by interaction of their
N-terminal domain with BECN1
With the finding that the EIF2AK2 binding domain of IRS1
and TRS1 is dispensable to their inhibitory effects, we tested
whether the autophagy machinery protein BECN1 is involved,
since several viral proteins interact with it. BECN1, the mam-
malian ortholog of yeast Vps30/Atg6, along with PIK3C3
(mammalian ortholog of yeast Vps34), which is the catalytic
subunit of the class III phosphatidylinositol 3-kinase
(PtdIns3K), and with other core autophagy proteins, forms sev-
eral complexes which are required for the initiation of autopha-
gosome formation and endocytic trafficking.21 The activity of
BECN1 is modulated by diverse cellular stimuli leading to
phosphorylation and ubiquitination modifications or to
Figure 2. IRS1 and TRS1 inhibit autophagy independently of EIF2AK2. (A and B) eif2ak2¡/¡ and Eif2ak2C/C MEFs were cotransfected with GFP-LC3 and IRS1 or TRS1 and
48 h later were grown in starvation medium for 4 h before fixation. (A) Representative images of GFP-LC3 with insets showing TRS1 or IRS1 expression (red), and (B) quan-
tification of GFP-LC3 dots per cell. (C) Immunoblot analysis of SQSTM1 protein in lysates of eif2ak2¡/¡ and Eif2ak2C/C MEFs transfected with IRS1 or TRS1 plasmids. (D)
Schematic representation of full-length and truncated IRS1 expression plasmids, showing positions of the dsRNA-binding domain (amino acids 74 to 248) and the EIF2AK2
binding domain (amino acids 669 to 692). (E) Representative images of GFP-LC3 HeLa cells transfected with the indicated IRS1 constructs and then starved for 4 h and (F)
quantification of GFP-LC3 dots. (G) Immunoblot analysis of SQSTM1 and LC3 proteins in HeLa cells transfected with the indicated IRS1 constructs. CM, complete medium.
, P<0.05; , P<0.01; , P<0.001 (One-way ANOVA).
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relocalization of BECN1 or via protein-protein interactions.21
For example, the antiapoptotic BCL2 family members can
interact with BECN1 and inhibit autophagy.22 We analyzed by
confocal microscopy the distribution of the 2 viral proteins and
BECN1 in MRC5 cells infected with HCMV for 24 h. The stain-
ing pattern of IRS1 and TRS1 was widespread in the cytoplasm
and BECN1 was labeled in punctate structures (Fig. 3A).
Importantly, TRS1 and IRS1 showed substantial overlap with
BECN1.
To investigate whether IRS1 interacts with BECN1, we per-
formed a coimmunoprecipitation experiments with 6£His-
tagged IRS1 and BECN1 plasmids. We found that IRS1 bound
to BECN1 (Fig. 3C). In order to delineate the domain of IRS1
which interacts with BECN1, we analyzed 2 truncations of
IRS1 from the amino termini, IRS1(45 to 847) and IRS1(93 to
847) (Fig. 3B). Coimmunoprecipitation experiments revealed
that the 2 amino-terminal mutants of IRS1 did not bind to
BECN1 (Fig. 3C). EGFP-His was used as a negative control and
full length IRS1 and TRS1 as positive controls. These results
demonstrated that deletion of the N-terminal domain of IRS1
abolishes the interaction with BECN1. BECN1 contains 3 major
protein binding domains, an N-terminal BH3 (BCL2 homology
3) domain, a central coiled-coil domain (CCD), and an evolu-
tionarily conserved domain at the C terminus.21 Using different
fragments of FLAG-BECN1 (Fig. 3B), we determined the
BECN1 domain that interacts with IRS1. IP assays showed that
the (141 to 450) and (141 to 265) BECN1 fragments immuno-
precipitated IRS1, indicating that IRS1 interacts with the CCD
domain of BECN1 (Fig. 3D). The (1 to 255) BECN1 fragment
did not interact with IRS1, possibly because of effects of the N
terminus on the folding of the truncated CCD.
We then assessed the ability of the amino-terminal trunca-
tions mutants of IRS1 to inhibit starvation-induced autophagy.
HeLa cells stably expressing GFP-LC3 were transiently trans-
fected with full-length IRS1, TRS1 or with 2 IRS1 N-terminal-
deleted fragments and GFP-LC3 dots were analyzed by immu-
nofluorescence. TRS1 was used as positive control. We
observed that IRS1 mutants (45 to 847) and (93 to 847) failed
to inhibit autophagy as efficiently as full-length IRS1 or TRS1
(Fig. 3E). We also observed that cellular levels of SQSTM1 only
partially increased in cells transfected with the 2 IRS1 mutants
compared to cells transfected with full-length IRS1 or TRS1
(Fig. 3F). Thus, the inhibition of autophagy by IRS1 requires its
N-terminus. These results suggest that IRS1 and TRS1 inhibit
autophagy as a result of their interaction with BECN1 by this
N-terminal domain.
IRS1 and TRS1 are both involved in the control of
autophagy during infection
In order to investigate the role of IRS1 and TRS1 in autophagy
blocking in the context of viral infection, we analyzed autoph-
agy in cells infected with HCMV mutants lacking either IRS1
or TRS1 genes or both (Fig. 4A and B). In HCMV-infected
cells, we observed, as previously reported,8,23 that the number
of autophagosomes was significantly decreased. In contrast, the
number of autophagosomes was significantly increased after
infection with mutant HCMV lacking both IRS1 and TRS1
(HCMV [DI-DT]), compared to mock-infected cells and
HCMV-infected cells. Furthermore, the IRS1 and TRS1 single
mutant viruses each inhibited autophagosome formation rela-
tive to HCMV [DI-DT], but not as strongly as the wild-type
(WT) virus. Accumulation of SQSTM1 confirmed that whereas
HCMV [DI-DT] drastically stimulated autophagy, WT HCMV
blocked autophagy and the 2 single mutant viruses had an
intermediate phenotype (Fig. 4C). Autophagic flux can be mea-
sured by inferring LC3-II turnover by western blot in the pres-
ence and absence of chloroquine (CQ). CQ neutralizes the
lysosomal pH and by inhibiting endogenous protein degrada-
tion causes the accumulation of LC3-II in either autophago-
somes or autolysosomes.24 The relevant parameter in this assay
is the ratio in the amount of LC3-II in the presence and absence
of CQ, which can be used to examine the transit of LC3-II
through the autophagic pathway. When autophagic flux is
occurring, the amount of LC3-II is higher in the presence of
CQ. As is evident in Figure 4D, HCMV infection leads to a sim-
ilar accumulation of LC3-II with and without CQ, whereas
none of the mutant viruses was able to do so. We previously
reported the accumulation of LC3-II in WT HCMV-infected
cells, which is not correlated with the number of autophago-
somes.8,23 This result suggests that the 2 viral proteins are nec-
essary to inhibit autophagic flux. In support of this hypothesis,
we found that cotransfection of IRS1 and TRS1 in HeLa cells
clearly led to LC3-II accumulation and a complete block of
autophagic flux (Fig. 4E). Taken together, these results demon-
strate that IRS1 and TRS1 are both involved in a complemen-
tary manner in the regulation of autophagy by HCMV.
The BECN1-binding-deficient TRS1 mutant virus is unable
to control autophagy
Next, we investigated the functional significance of TRS1 and
IRS1 interaction with BECN1 in the context of HCMV infec-
tion. Based on a previously described BAC-derived HCMV
strain AD169 lacking both TRS1 and IRS1,14 we constructed
mutant viruses in which an HA-tagged version of the TRS1
gene was reintroduced either with a deletion of amino acids 1
to 44 (referred to as TRS1(45–795)-DIRS1 HCMV) or the com-
plete gene (referred to as TRS1HA-DIRS1 HCMV) (Fig. 5A).
TRS1(45–795)- DIRS1 HCMV and TRS1HA- DIRS1 HCMV
express a protein of the predicted molecular weight (80 kDa
and 85 kDa, respectively) that reacts with an anti-TRS1 and
anti-IRS1 antibody (Fig. 5B). Whereas TRS1 coimmunoprecipi-
tates with BECN1 in TRS1HA-DIRS1 HCMV infected cells,
interaction between TRS1(45–795) and BECN1 is greatly
reduced (Fig. 5C). We evaluated the ability of this BECN1-
binding-deficient TRS1 mutant virus to control autophagy
measuring accumulation of GFP-LC3 dots and SQSTM1 and
LC3 immunoblots. We observed that infection with TRS1(45–
795)-DIRS1 HCMV did not decrease the number of autophago-
somes compared to mock-infected cells while the repaired
virus, TRS1HA- DIRS1 HCMV, partially inhibited autophagy
(Fig. 5D). Moreover, TRS1(45–795)-DIRS1-infected cells accu-
mulated less SQSTM1 protein and more LC3-II compared to
TRS1HA- DIRS1-infected cells (Fig. 5E). Adding CQ showed
that only the parental BAC-derived AD169 blocked autophagic
flux, in agreement with our previous results (Fig. 4). Taken
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together, these results show that the BECN1-binding-deficient-
TRS1 mutant virus is not able to inhibit autophagy.
An HCMV recombinant virus containing a mutation in
TRS1 that abrogates binding to BECN1 does not have a
growth defect
We sought to determine whether the interaction of TRS1 with
BECN1 and the ability to block autophagy is important for
virus replication. We hypothesized that a virus that is unable to
control autophagy by virtue of deletion of all of IRS1 and the
BBD of TRS1 would replicate less efficiently. We therefore ana-
lyzed the growth kinetics of the different mutant viruses in
human fibroblasts (Fig. 6). The multiple-step growth kinetics of
wild-type (AD169-BAC) and deletion mutant viruses were
examined in cells infected at a low multiplicity of infection and
virus titers were determined. The TRS1(45–795)-DIRS1
Figure 3. IRS1 interacts with BECN1 and inhibits autophagy via its N-terminal region. (A) Colocalization of IRS1 and TRS1 with BECN1 in MRC5 cells infected with HCMV
24 h pi by confocal microscopy. (B) Schematic representations of different IRS1 N-terminal-deleted fragments and BECN1-deleted fragments. (C) Immunoprecipitation
assays of BECN1 in HeLa cells transfected with EGFP-His, different constructs of His-IRS1 or full length His-TRS1. (D) Immunoprecipitation assays of FLAG-BECN1 in HeLa
cells transfected with full-length His-IRS1 and different constructs of BECN1. (E) GFP-LC3 dots were quantified in GFP-LC3 HeLa cells transfected for 48 h with the indicated
IRS1 constructs. (F) Immunoblot analysis of SQSTM1 levels in HeLa cells transfected with the indicated constructs and then grown in starvation medium for 4 h before cell
lysis. The results are the mean of 3 experiments; 100 cells were analyzed per assay. , P<0.01 (One-way ANOVA).
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recombinant virus achieved titers comparable to those of
TRS1HA-DIRS1 and AD169-BAC (Fig. 6A). When MRC5 cells
were infected with HCMV [DI-DT], no progeny virus was
detected for the duration of the assay (20 days), consistent with
the previous report.25 For single-step growth analysis, the pro-
duction of extracellular virus and intracellular virus was studied
at the indicated times after infection.26 The amount of infec-
tious virus produced at various times post infection (pi) was
determined by using an immunoenzymatic assay in which the
number of immediate early antigen (IEA)-positive cells was
determined at 2 d pi (see Materials and Methods). Compared
to the wild type (AD169-BAC), the TRS1(45–795)-DIRS1
mutant virus produced similar amounts of infectious intracellu-
lar and extracellular virus at 4 and 6 d pi (Fig. 6B). This set of
experiments indicates that lack of control of autophagy confers
no growth disadvantage to the mutant virus.
HCMV transcribes its genes in a temporal manner, which is
classified into 3 stages: immediate-early, early, and late. We
used immunoblot assays to monitor expression of the immedi-
ate early (IE1 and IE2) proteins, TRS1 and IRS1 proteins and a
late (pp28) protein in cells infected for 1, 2 or 5 d with the
various viruses (Fig. 6C). IE1 and IE2 proteins were expressed
at identical levels in cells infected with any of the viruses, at any
time pi. We also detected similar expression of the late protein
pp28 5 d pi. We then examined viral genome accumulation rel-
ative to cellular gene copies at different times pi (Fig. 6D). Viral
DNA of TRS1(45–795)-DIRS1 mutant virus accumulated to
similar levels as WT virus. Together, these results suggest that
the IRS1 and TRS1 autophagy modulating activity does not
have a direct role in promoting viral replication in terms of
viral protein expression, viral DNA replication, viral produc-
tion or release in human fibroblasts.
Inhibition of autophagy decreases viral production
Finally, with the aim of clarifying the impact of autophagy
modulation on viral replication, we sought to determine
whether modulation of autophagy by pharmacological
approaches could impact the viral multiplication. We used
serum starvation, rapamycin and methyl b cyclodextrin
(MbCD) treatment to induce the formation of autophago-
somes.27 These treatments stimulated autophagy in MRC5 cells
Figure 4. IRS1 and TRS1 are involved in the inhibition of autophagy after HCMV infection. (A) MRC5 cells were mock-infected or infected with HCMV, DIRS1-DTRS1, DIRS1
and DTRS1 mutant viruses at an MOI of 1, transfected with GFP-LC3 and then fixed at 24 h pi. Cells were fixed and immunostained for pp65 or IEA viral proteins as indi-
cated (scale bar: 10 mm). (B) GFP-LC3 dots were quantified in pp65- or IEA-positive cells. The results are the mean of 6 independent experiments. Twenty-five cells were
counted per assay. , P<0.01; , P<0.001 (One-way ANOVA). (C and D) Immunoblot analysis of SQSTM1 and LC3 proteins in mock-infected MRC5 cells or infected with
WT HCMV or the indicated mutant viruses for 24 h. (E) Immunoblot analysis of LC3 protein in cells transfected with the indicated constructs for 24 h and grown in starva-
tion medium for 4 h before cell lysis. (D and E) Chloroquine was added 4 h before lysis to monitor autophagic flux.
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(Fig. 7A).8,23 Then, we infected cells with HCMV at low multi-
plicity of infection (MOI) and treated them from 18 h to 4 d pi.
This protocol enabled us to avoid nonspecific effects of the
drugs on viral entry and early stages of the viral cycle. We
observed that extracellular and intracellular viral production
was higher in starved cells and in cells treated with MbCD or
rapamycin than in nontreated cells (Fig. 7B). Next, we evalu-
ated the effect of Spautin 1, a potent and specific inhibitor of
autophagy (Fig. 7A), on viral production.28 As shown in
Figure 7C, we observed that Spautin 1-repressed autophagy
inhibited viral replication. In cells infected at low MOI and
treated with Spautin 1, both intra and extra cellular viral
productions were strongly decreased compared to nontreated
cells. These results suggest that autophagy is able to modulate
viral production but does not affect viral exit from infected
cells, since the effect is similar on extra and intracellular pro-
duction. To investigate whether cellular autophagy regulates
HCMV at the replication level, we examined by qPCR the
effects of these drugs added 18 h pi on viral genome accumula-
tion. Figure 7D shows that Spautin 1 treatment profoundly
decreased viral DNA replication. No effect of starved-induced
autophagy induction was observed whereas MbCD and rapa-
mycin decreased DNA replication by 40%. Finally, quantifica-
tion of infected cells 4 d pi after different modulating
Figure 5. The BECN1-binding-deficient TRS1 mutant virus does not inhibit autophagy. (A) Schematic representation of the HA-tagged TRS1 recombinant viruses. (B)
Expression of TRS1 and IRS1, detected by immunoblotting with anti-TRS1 and IRS1 antibody of cells lysates after infection with the indicated viruses. (C) MRC5 cells were
infected with TRS1(45–795)-DIRS1 and TRS1HA-DIRS1 recombinant viruses for 48 h. Cells were immunoprecipitated with a goat anti BECN1 antibody, followed by immu-
noblotting with an anti-HA antibody and anti-BECN1. (D) MRC5 cells were infected with the indicated viruses, transfected with GFP-LC3 and then fixed 24 h pi. Autophagy
was quantified in IEA-positive cells by counting the number of GFP-LC3 dots per cell. The results are the mean of 3 independent experiments. Twenty cells were counted
per assay. , P<0.001 (One-way ANOVA). (E) Immunoblot analysis of SQSTM1 and LC3 levels in MRC5 cells infected with the indicated viruses at MOI 1. ACTB was used
as a loading control. CQ, chloroquine.
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treatments confirmed that induction of autophagy increased
the level of infection and conversely, inhibition strongly
reduced it (Fig. 7E).
To complement these studies using pharmacological modu-
lation of autophagy, we also conducted genetics experiments.
ATG16L1 forms a complex with ATG5 and ATG12 that is
essential for autophagosome biogenesis. We therefore estab-
lished human foreskin fibroblasts stably expressing ATG16L1
shRNA or scrambled shRNA. We confirmed successful knock-
down of the ATG16L1 protein and analyzed its effects on
autophagy by ATG16L1, SQTSM1 and LC3 immunoblot assays
(Fig. 7F). Knocking down ATG16L1 with either of 2 shRNAs
decreased autophagy compared to scrambled shRNA control.
After infection with WT HCMV at MOI 0.02, we observed that
viral DNA replication was decreased in both ATG16L1 knock-
down cells compared to the control cell line (Fig. 7G). We
observed that expression of TRS1 and IRS1 was similar in the 3
cell lines. We examined the effect of shRNA-mediated
downregulation on expression of immediate early proteins 4 d
pi, which reflect level of infection. Blocking autophagosome
formation significantly reduced HCMV infection (Fig. 7G).
These results provide additional evidence that inhibition of
autophagy reduces HCMV infection.
Discussion
In this report, we demonstrated that HCMV blocks both auto-
phagosome formation and maturation, dependently of viral pro-
tein synthesis. We previously identified an antiautophagic
function of the viral protein TRS1 and we report here that IRS1,
which has homologous regions with TRS1, is also able to decrease
the accumulation of autophagosomes.8,9 Based on several read-
outs to monitor autophagic activity, we demonstrated that
autophagy is inhibited by both TRS1 and IRS1 proteins in starved
and in infected cells.24 The use of a high throughput microscopy
approach, previously developed by McKnight et al.,29 allowed us
Figure 6. Characterization of a HCMV recombinant virus containing a mutation in TRS1 that abrogates binding to BECN1. (A) Multiple-step growth analysis. MRC5 cells
were infected at MOI of 0.02 with the indicated viruses. Cultures were harvested at the indicated times pi, and viral titers were determined by TCID50 assay. Results repre-
sent the averages of 3 independent experiments. (B) Single step growth analysis was performed to examine the production of extracellular virus and intracellular virus.
MRC5 cells were infected at MOI 0.5 with AD169-BAC (WT), TRS1(45–795)-DIRS1, or TRS1HA-DIRS1 recombinant viruses. Infected cell culture medium were harvested at
the indicated times pi (cell-free), and intracellular virus was isolated by freezing and thawing cell pellets (cell associated). The amount of virus present in each sample was
determined by infecting MRC5 cells with these samples and counting the number of IEA-positive cells. Results represent the averages of 2 independent experiments. (C)
Lysates from HCMV-infected cells were prepared at 1, 2 and 5 d pi and immunoblotted using antibodies specific for IEA, ap999 antiserum specific for pIRS1 and pTRS1,
and for pp28. (D) Viral DNA genome after infection of MRC5 cells with the indicated viruses, 2 to 4 d pi.
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to precisely quantify the ability of TRS1 or IRS1 expression to
decrease not only the number of GFP-LC3 dots but also the inten-
sity of the dots and the total area covered by the GFP-LC3 positive
dots. Only the size of autophagosomes remained unchanged.
Moreover, we noticed that simultaneous expression of TRS1 and
IRS1 leads to a block of the autophagic flux.
In order to examine the respective roles of TRS1 and IRS1 in
the context of infection, we constructed mutant viruses that do
not express TRS1, or IRS1 or either protein. Whereas the 2
viruses lacking either TRS1 or IRS1 each partially control
autophagy, deletion of both proteins leads to a marked stimula-
tion of autophagy. However, it is important to note that
Figure 7. Autophagy affects HCMV infection. (A) SQSTM1 immunoblots and LC3 staining in MRC5 cells under starvation or after the indicated treatments. (B) MRC5 cells
were infected with HCMV (MOI 0.02), treated with MbCD, rapamycin or serum starved 18 h pi and analyzed for viral production after 4 d. (C) MRC5 cells were infected in
the same conditions then treated with Spautin 1 and viral production was analyzed. (D) Viral DNA genome replication after the indicated treatments 4 d pi. (E) Images
and quantification of IEA expression in MRC5 cells infected with HCMV for 4 d and treated with the indicated drugs. Representative assay of 3 independent experiments
(F) Immunoblot analysis of ATG16L1, LC3, SQSTM1 and viral proteins expression in ATG16L1 shRNA- or scrambled RNA-expressing cells. (G) Viral DNA genome replication
and IEA expression after 4 d. NT no treatment.
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HCMV [DI-DT] does not replicate in wild-type fibroblasts, as a
result of protein synthesis shutoff.14 Most viral proteins are
therefore not expressed. In the same way, when all de novo viral
protein expression is prevented by UV-inactivation, HCMV
stimulates autophagy.8 We also demonstrated that HCMV
infection leads to a profound inhibition of the autophagic flux,
resulting of an accumulation of LC3-II. Both TRS1 and IRS1
are necessary to clearly establish this blockade, since none of
the single deletion mutant viruses is able to act the same way as
WT virus.
We characterized the mechanism by which the viral proteins
modulate autophagy. TRS1 and IRS1 have been identified as
viral tegument proteins that localize to the nucleus and cyto-
plasm in infected cells.30,31 They both have been reported to
activate transcription in cooperation with other viral activators
and TRS1 might be involved in the assembly of virus cap-
sids.12,32-34 Both TRS1 and IRS1 interact with UL44, a proces-
sivity factor of the DNA polymerase, but not simultaneously.35
TRS1 has recently been reported to bind to mRNA caps and
stimulate translation.36 However, the best-characterized func-
tion known for these 2 large proteins is the repression of
EIF2AK2 activity.14 In addition to a dsRNA binding domain
that is identical in TRS1 and IRS1, they both have homologous
but not identical C-terminal regions that are required for bind-
ing to EIF2AK2. Interestingly, we have previously demon-
strated that the herpes simplex virus type 1 (HSV-1) late
protein Us11 is able to block autophagy, by direct interaction
with EIF2AK2.20 However, we demonstrated here that the
mechanism by which TRS1 and IRS1 inhibit autophagy is inde-
pendent of their activity on EIF2AK2. Instead, TRS1 and IRS1
colocalize with and bind to the autophagy machinery protein
BECN1. Moreover, their identical N-terminal regions are
required both for this interaction and for their antiautophagic
activity. Interestingly, this region of IRS1 or TRS1 is not
required for interaction with UL44, EIF2AK2 or dsRNA.15,16,35
Several viral proteins that are able to modulate autophagy
act by interaction with BECN1.21 Whereas the adenovirus
E1B19K protein triggers autophagy by displacement of the
antiautophagic protein, BCL2, from the BECN1 interactome,37
all the other viral BECN1-interacting proteins disrupt autoph-
agy, either at the autophagosome formation or at the matura-
tion step.21 The Nef protein of HIV-1,38 M2 protein of
influenza virus39 and ICP34.5 of HSV-140 suppress autophago-
some maturation into autolysosomes, likewise via their interac-
tion with BECN1.22 Viral encoded BCL2 proteins block
autophagosome formation through a direct interaction with
the BH3 domain of BECN1, as does cellular BCL2,22 while
HSV-1 ICP34.5 and HCMV IRS1 do not interact with the BH3
domain of BECN1.19 We found that the CCD domain in
BECN1, a universal oligomerization domain, is the binding
domain of IRS1. Notably, this CCD domain allows ATG14 and
UVRAG (UV radiation resistance associated) to interact with
BECN1 respectively in 2 distinct PtdIns3K-containing com-
plexes that function differentially in autophagy formation and
in maturation of the endosome and the autophagosome.41
Interestingly, our results suggest that individually IRS1 and
TRS1 may block autophagosome biogenesis through the
PtdIns3K-BECN1-ATG14 complex, and coexpression of them
may block the maturation process through the PtdIns3K-
BECN1-UVRAG complex.
Infection with HCMV [DI-DT] virus leads to a global shut-
down of proteins synthesis because of the lack of control of
EIF2AK2.25 In order to retain the inhibitory activity of TRS1
on EIF2AK2 (but not on BECN1), we constructed an HCMV
DIRS1 recombinant virus containing a mutation in TRS1 that
abrogates binding to BECN1 (TRS1(45–795)-DIRS1). We
found that this virus is not able to inhibit autophagy. This find-
ing supports that conclusion that HCMV uses both TRS1 and
IRS1 to block autophagy.
Autophagy can contribute to antiviral defenses and it has
been reported in others studies that autophagy can directly
reduce viral multiplication. For example, autophagy has an
inhibitory effect on chikungunya virus propagation.42 In the
case of HCMV, our results show that the inability to control of
autophagy by the mutant virus HCMV TRS1(45–795)-DIRS1
has no impact on viral multiplication. Viral protein expression,
viral replication, intracellular viral production, and viral release
were not different in HCMV TRS1(45–795)-DIRS1-infected
cells compared to WT virus, suggesting that, at least in cultured
human fibroblasts, autophagy is not detrimental to viral propa-
gation. It is interesting to note that HSV-1 lacking the ICP34.5
BECN1-binding domain grows as well as WT HSV-1 in fibro-
blasts in vitro but is clearly neuroattenuated in mice.19 It is pos-
sible that inhibition of autophagy by HCMV may be immune-
response related and therefore apparent in natural infections of
humans but not in fibroblast culture. It will be interesting to
explore whether HCMV has different consequences in other
cells types. We noted that the TRS1(45–795)-DIRS1 recombi-
nant virus, unlike the HCMV [DI-DT], does not stimulate
autophagy after 24 h of infection although autophagy is
induced by this virus quickly after infection, in the same man-
ner as WT virus (data not shown). Among the possible explan-
ations for these results is that another viral protein, not
expressed in HCMV [DI-DT]-infected cells but expressed by
this virus, participates to the control of autophagy. This might
explain the lack of effect on viral replication. Further investiga-
tions will be needed to determine whether HCM encodes addi-
tional autophagy-modulating proteins.
Since the recombinant virus TRS1(45–795)-DIRS1 seems
not able to fully block autophagy, we decided to use pharmaco-
logical approaches and ATG16L1 knockdown cells to study the
impact of the modulation of autophagy on viral multiplication.
Surprisingly, we observed that activation of autophagy
enhanced HCMV infectivity, whereas its inhibition decreased
viral production. We noticed similar effects of the drugs on
extra and intracellular viral yields, suggesting that autophagy
does not influence release of the virus. Viral DNA replication
was severely repressed by autophagy inhibition but was not
increased by autophagy induction. These findings suggest that
stimulation of autophagy may contribute to HCMV infection
after viral DNA replication. Conversely, inhibition of autoph-
agy seems to have an impact earlier in the viral replication
cycle. Taken together, these results show that autophagy has a
proviral role in HCMV replication. These unexpected findings
in HCMV exhibit similarities with recent report of a proviral
role for autophagy during Epstein Barr virus reactivation, a
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gammaherpesvirus.43 The Epstein Barr virus inhibits autopha-
gosome degradation and seems to utilize the molecular
machinery of autophagy for its envelope. Another Herpesvirus,
varicella zoster virus induces an autophagic response which has
a proviral effect, that may be related to the fact that autophagy
improves biosynthesis and processing of the viral glycoprotein
gE.44 In fact, one has to wonder whether HCMV subverts auto-
phagosome formation and maturation in order to avoid degra-
dation in some cell types and to utilize the autophagic
machinery to its own profit. Indeed, recent studies have dem-
onstrated that several DNA viruses utilize autophagosomes or
the autophagic process to benefit their viral life cycle. For exam-
ple, autophagy positively affects infection of adenovirus, hepati-
tis B virus, and human BK polyomavirus.45–47 Interestingly,
inhibition of autophagy is now considered to be possibly used
as a therapeutic strategy in cancer and in neurodegenerative




Primary human embryonic lung fibroblasts MRC5 were pur-
chased from Biomerieux, and used between passages 23 and 28
post isolation. These cells were maintained in minimum essen-
tial medium (Gibco®, 21090–022) supplemented with 10% fetal
calf serum (FCS), penicillin G (100U/ML), streptomycin sulfate
(100mg/ml), L-glutamine (1%), and nonessential amino acids
(1%). HeLa cells were cultured in RPMI (Gibco®, 61870–10)
10% FCS. GFP-LC3 stably-transfected HeLa cells50 were pro-
vided by Aviva Tolkovsky, (Cambridge Centre for Brain Repair,
Cambridge, UK) and were grown in RPMI 10% FCS with 500
mg/ml of G418. Eif2ak2C/C and eif2ak2¡/¡ MEFs kindly pro-
vided by B. R. G. Williams (Monash University, Victoria, Aus-
tralia), and human foreskin fibroblasts, provided by Thomas
Shenk (MolBio Department, Princeton University, Princeton
USA) were maintained in DMEM (Gibco®, 41965–039) supple-
mented with 10% FCS. The pTRS1-expressing cell line, HF-
2.7bTRS1 was described elsewhere.14 The WT virus used in
this study was the AD169 strain. The AD169 strain of HCMV
was obtained from ATCC and was propagated in MRC5 cells
as previously described.51 All mutant viruses were constructed
on the basis of the AD169 bacterial artificial chromosome
(BAC), which contains the full-length genome of the HCMV
AD169 strain.52 The AD169-BAC (WT) virus and the mutants
AD169 DIRS1, AD169 DTRS1, and AD169 DIRS1-DTRS1 are
previously described.14 The mutants TRS1HA-DIRS1 and
TRS1(45–795)-DIRS1 were generated by reinserting either the
full-length TRS1 coding sequence or a truncated TRS1
sequence lacking the first 44 codons into the AD169 DIRS1-
DTRS1 BAC. Briefly, oligonucleotide primers containing 50-
nucleotide homologies immediately up- and downstream of
TRS1 were used to amplify HA-tagged TRS1 and a kanamycin
resistance marker flanked by FLP recombination target (FRT)





CAGCTGCAAAAGAAAACCAGT-30. For the truncated TRS1,
50-TGACGCGGGTTTGCTTCCTATATAGTGGACGTCG-
GAGGTGTCCGGCGCCCATGACTGGTGCGAGTGCTGC-
30 and the same reverse primer as for full-length TRS1 was
used. Plasmid pBS-TRS1HA-fk served as PCR template. The
PCR product was used to insert the full-length or truncated
TRS1 gene into the AD169 DIRS1-DTRS1 BAC by homologous
recombination in Escherichia coli strain EL250.53 The kanamy-
cin resistance marker was subsequently removed by arabinose-
induced FLP recombinase as described.53 All the recombinant
viruses, except the AD169 DIRS1-DTRS1 virus, were propa-
gated and their titers were determined in MRC5 cells. The
AD169 DIRS1-DTRS1 virus was grown and its titer was deter-
mined in HF-2.7bTRS1 cells.
Pharmacological modulators of autophagy
The compounds 3MA (M9281), Spautin 1 (SML0440), rapamy-
cin (R8781) and MbCD (C4555) were purchased from Sigma
and the concentrations used were 10 mM, 10 mM, 5 nM and
5 mM, respectively. When indicated, drugs were applied to cul-
tured infected cells 18 h pi. Chloroquine (Sigma, C6628) was
used at 50 mM 4 h previous cell lysis to block autophagic
degradation.
Plasmids
The GFP-LC3 expression vector was kindly provided by
Tamotsu Yoshimori (Research Institute for Microbial Diseases,
Osaka University, Osaka, Japan).54 The FLAG-ICP34.5 plasmid
was a gift from Bin He (University of Illinois, Chicago, USA).55
The FLAG-tagged BECN1 plasmids were a kind gift of Beth
Levine (UT Southwestern, Dallas, USA). The pEQ1180 con-
struct expresses full-length HCMV TRS1 protein cDNA.56 The
pEQ1100 construct expresses enhanced green fluorescent pro-
tein (EGFP) (5). The pEQ1007 construct, containing a full-
length HCMV IRS1 protein cDNA and the pEQ1002 (1 to
656), pEQ1010 (1 to 668), pEQ1033 (1 to 692) constructs, con-
taining the indicated lengths of IRS1, have been previously
described.16 The plasmids pEQ1455 (45 to 847) and pEQ1456
(93 to 847) were constructed by PCR amplification of pEQ1007
using forward primers 50 ACCATGGGTGCAAGTACTGCG
GGTTCG-30 or 50-ACCATGGTGGA-GCGGCAGGCGCTG-
30, respectively, with the reverse primer 50-ATGATGAACGT
GGTGAGGG-GCGTGT-30.16 The resulting PCR product was
cloned into pcDNA3.1/V5-His-TOPO (Invitrogen). All of these
constructs have a carboxyl–terminal 6-His tag. Transfections
were performed using the FuGENE HD transfection reagent
(Roche), as previously described.8 Starvation-induced autoph-
agy was carried out by culturing the cells in Earle’s Balanced
Salt Solution (EBSS, GIBCO) for 4 h before fixation.
Antibodies
To detect HCMV-infected cells, we used a murine monoclonal
antibody directed against the viral proteins IE1 and IE2 (clone
E13; Biomerieux, 11–003) and a murine monoclonal antibody
directed against the tegument protein pp65 (Biomerieux, 11–
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002). A mouse monoclonal antibody against the late protein
pp28 (clone CH19, sc-69749) was purchased from Santa Cruz.
To detect His- and FLAG-tagged constructions, we used a rab-
bit antibody directed against 6xHis (Cell Signaling Technology,
2365) or a mouse antibody against FLAG (Sigma, F3165).
Additional primary antibodies used in this study included anti-
SQSTM1 (Abnova clone 2C11, H00008878-M01), anti-BECN1
(BD bioscience, 612112), anti-ATG16L1 (Clinisciences,
PM040), and anti-ACTB/b-actin (Merck Millipore MAB1501
clone C4). For immunoprecipitation of BECN1, we used a goat
antibody provided by Santa Cruz Biotechnology (sc-16647).
Secondary fluorescein isothiocyanate (FITC), tetramethyl rho-
damine isothiocyanate (TRITC)-conjugated, horseradish per-
oxidase-labeled goat anti-mouse or anti-rabbit secondary
antibodies were purchased from Jackson ImmunoResearch
Laboratories (115–035–003, 111–035–003). The IRS1-TRS1
rabbit polyclonal antiserum ap999 directed against amino acids
74 to 248 of TRS1 has been previously described.14
Coimmunoprecipitation assays
To study the interaction between BECN1 and IRS1 or TRS1,
HeLa cells were transfected to coexpress BECN1, and the vari-
ous molecular partners (EGFP-His, His-IRS1, His-TRS1, IRS1
(45 to 847) and IRS1(93 to 847) proteins). To identify the inter-
action domain of BECN1 with IRS1, HeLa cells were cotrans-
fected with different constructions of FLAG-BECN1 and His-
IRS1. To study the interaction between TRS1 and endogenous
BECN1 in the context of infection, MRC5 cells were infected
with a mutant virus TRS1(45–795)-DIRS1 or the repair virus
TRS1HA-DIRS1. Forty-eight h after transfection or infection,
the cells were washed with cold, sterile phosphate-buffered
saline (PBS; Gibco®, 14200–067) and then lysed at 4C for 2 h
in lysis buffer (50 mM Tris HCl, 50 mM NaCl, 0.5% Triton X-
100 (Sigma, T-8787) 0.5% deoxycholic acid (Sigma, D-6750),
0.2% bovine serum albumin (Sigma, A1595), 25 mM NaPPi,
50 mM NAF, 1 mM Na3VO4) followed by ultracentrifugation
at 274,000xg at 4C for 30 min to remove cell debris. Immuno-
precipitation was performed overnight at 4C with a goat poly-
clonal anti-BECN1 antibody or a mouse anti-FLAG antibody.
Protein G-Sepharose beads were added for 1 h at 4C and were
washed 3 times with lysis buffer and 2 times with wash buffer
(20 mM Tris HCl, 50 mM NaCl, 0.2% bovine serum albumin).
The immune complexes were finally boiled for 5 min in loading
buffer (62.5 mM Tris, pH 6.8, 10% glycerol, 1.5% SDS, 0.025%
bromophenol blue, 8% b-mercaptoethanol) before being ana-
lyzed by SDS-PAGE.
Immunoblot analysis
MRC5 and HeLa cells were lysed in 65 mM Tris, pH 6.8, 4%
SDS, 1.5% b-mercaptoethanol, and held at 100C for 5 min.
After SDS-PAGE, the proteins were electrotransferred onto a
polyvinylidene difluoride membrane. After incubation in
blocking buffer, the blots were probed overnight with specific
antibodies, then incubated with secondary antibodies, followed
by chemiluminescent detection, according to the manufac-
turer’s instructions (Immobilon, Millipore). Scanning for quan-
tification was monitored using ImageJ software.
Immunofluorescence analysis
Cell monolayers were washed 3 times with PBS, and then fixed
with 3.5% paraformaldehyde in PBS or acetone. The cells were
permeabilized using 0.2% Triton X-100 in PBS and incubated
for 1 h in blocking buffer, and then with appropriate primary
antibodies for 1 h or overnight. The cells were washed 3 times,
and then incubated with appropriate secondary antibodies. To
detect IRS1 or TRS1 expression, cells were stained with mouse
anti-His Mab or rabbit anti-IRS1-TRS1 serum. Coverslips were
mounted in Glycergel (Dako, C0563) and examined using a
Nikon Eclipse 80i epifluorescence microscope (Nikon instru-
ments, Champigny sur Marne, France) or a LSM510 Zeiss con-
focal microscope (Carl Zeiss Microscopy, Iena, Germany).
Digitized images were stored, and overlaid to evaluate 2-color
experiments. Photographic images were resized, organized, and
labeled using Adobe Photoshop software.
Optimized automated quantification of GFP-LC3 dots by
high throughput microscopy
GFP-LC3 HeLa cells were transfected with empty vector, IRS1
or TRS1 and fixed after 4 h of starvation. GFP-LC3 dots were
quantified using a Thermo Cellomics ArrayScan VTI HCS
Reader (Thermo Fisher, Pittsburgh, PA, USA). The analysis
program detected DAPI-labeled nuclei, cell outline, GFP-LC3
dots and nontransfected rejected cells. The number of GFP-
LC3 dots per cell, the total intensity of GFP-LC3 dots per cell,
the total area covered by GFP-LC3 dots per cell and the average
area covered by GFP-LC3 dots per well were determined by the
ID view software.
Virus production
For multistep growth analysis, supernatant fractions of infected
cells were harvested at the indicated times after infection at a
MOI of 0.02 and virus titers were determined in triplicate by
50% tissue culture infective dose (TCID50) assay. For single-
step growth analysis, viruses were collected from both cell-free
supernatant fractions and infected cells at various time points
pi and quantified as previously described.26 Cell-associated
virus was isolated through 3 rounds of freezing and thawing in
a liquid nitrogen bath. Serial dilutions of virus samples were
plated on MRC5 cells. Infected cells were fixed 48 h pi and per-
meabilized in acetone/water at ¡20C for 20 min. IEA-positive
cells were labeled using the primary mouse antibody against
IEA (clone E13) and the secondary goat anti-mouse antibody
conjugated with horseradish peroxidase, and positive cells were
quantified at the appropriate dilution. To determine viral DNA
levels in infected cells, cells were harvested and lysed in the
presence of proteinase K and total DNA was purified using the
DNeasy Blood and Tissue kit (Qiagen, 69506) according to the
manufacturer’s instructions. Real-time PCR was performed
using Taqman probes and primers specific for the UL123 viral
gene, and ACTB or CXCR4 cellular genes, as previously
described.57
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Lentiviral delivery of shRNA
Stable ATG16L1 and scrambled shRNA cells were generated
using MISSION shRNA lentiviruses, which were kindly pro-
vided by Patrice Codogno (INEM, Paris, France). Stable cells
were cultured in puromycin-containing media (5 mg/ml; Inviv-
oGen anti-pr-1).
Statistics
Data are expressed as means § standard error of the means
(SEM) and were analyzed with Prism software (GraphPad ver-
sion 6.0) by using one-way analysis of variance (ANOVA), fol-
lowed by the Dunnett test comparisons. P values less than 0.05
were considered statistically significant. Experiments were per-




BAC bacterial artificial chromosome
BBD BECN1- binding domain
CCD coiled-coil domain
CQ chloroquine; dsRNA, double-stranded RNA
EIF2AK2/PKR eukaryotic translation initiation factor 2-a
kinase 2
EIF2S1 eukaryotic translation initiation factor 2 sub-
unit a
FCS fetal calf serum
HCMV human cytomegalovirus
HSV-1 herpes simplex virus type 1
ICP34.5 infected cell protein 34.5
IE1 and IE2 immediate early proteins
IRS1 internal repeat short protein 1
MAP1LC3/LC3 microtubule-associated protein 1 light chain
3
MbCD methyl b cyclodextrin
MEF mouse embryonic fibroblast
MOI multiplicity of infection




TRS1 terminal repeat short protein 1
UVRAG UV radiation resistance associated
WT wild type
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